Carl Byrnes

Stock Analyst at Northland Capital Markets

(0.27)
# 2180
Out of 5,253 analysts
31
Total ratings
62.50%
Success rate
8.60%
Average return
19 Stocks
Name Action Price Target Current % Upside Ratings Updated
BioLife Solns
Maintains: Outperform
28 31
28.47 8.89% 2 Jan 8, 2025
TriSalus Life Scienc...
Initiates Coverage On: Outperform
13
5.24 138.55% 1 Oct 25, 2024
BrainsWay
Maintains: Outperform
11 13
10.75 16.28% 3 Oct 3, 2024
Oncternal Therapeuti...
Downgrades: Market Perform
2
n/a n/a 1 Sep 12, 2024
Spectral AI
Initiates Coverage On: Outperform
6
1.79 235.2% 1 Aug 12, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
n/a
n/a n/a 1 Dec 21, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Market Perform
2 2
0.58 115.52% 1 Jul 19, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
8
0.45 1677.78% 1 May 22, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
2 1
n/a n/a 1 Dec 28, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
2 18
n/a n/a 2 Sep 16, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
60 80
14.34 457.88% 4 Aug 17, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
n/a
n/a n/a 1 Nov 19, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
9
n/a n/a 1 Nov 17, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
9
n/a n/a 1 Oct 14, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
23
9.11 152.47% 3 Jul 26, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Market Perform
30 24
1.96 1124.49% 4 May 5, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
128
n/a n/a 1 Apr 8, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
2000
1.72 116179.07% 1 Oct 22, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
n/a
n/a n/a 1 Sep 27, 2017